Human papillomavirus 16E6 and NFX1-123 potentiate notch signaling and differentiation without activating cellular arrest

Virology

Volumn 478, Issue , 2015, Pages 50-60

  Vliet Gregg, Portia A ^a   Hamilton, Jennifer R ^a,c   Katzenellenbogen, Rachel A ^a,b  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cycle; Differentiation; HPV E6; Keratinocytes; NFX1 123; Notch

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYTOKERATIN 1; CYTOKERATIN 10; CYTOPLASM PROTEIN; KI 67 ANTIGEN; NOTCH RECEPTOR; NOTCH1 RECEPTOR; PROTEIN NFX1 123; REGULATOR PROTEIN; UNCLASSIFIED DRUG; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; NFX1 PROTEIN, HUMAN; NOTCH1 PROTEIN, HUMAN; ONCOPROTEIN; REPRESSOR PROTEIN;

ARTICLE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL GROWTH; GENE; GENE OVEREXPRESSION; GROWTH DISORDER; HES1 GENE; HES5 GENE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS 16E6; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; CELL CULTURE; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16;

CELL DIFFERENTIATION; CELLS, CULTURED; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; RECEPTOR, NOTCH1; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 84923303676     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2015.02.002     Document Type: Article

References (37)

1. Ault K.A., Allen H.K., Phillips S.L., Zimmerman M.B., Klingelhutz A.J. Telomerase activity as a potential diagnostic marker for triage of abnormal Pap smears. J. Low. Genit.Tract Dis. 2005, 9:93-99.
2. Bajaj J., Maliekal T.T., Vivien E., Pattabiraman C., Srivastava S., Krishnamurthy H., Giri V., Subramanyam D., Krishna S. Notch signaling in CD66+ cells drives the progression of human cervical cancers. Cancer Res. 2011, 71:4888-4897.
3. Bartz S.R., Vodicka M.A. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Methods 1997, 12:337-342.
4. Borggrefe T., Oswald F. The Notch signaling pathway: transcriptional regulation at Notch target genes. Cell Mol. Life Sci. 2009, 66:1631-1646.
5. Branca M., Giorgi C., Ciotti M., Santini D., Di B.L., Costa S., Benedetto A., Bonifacio D., Di B.P., Paba P., Accardi L., Mariani L., Ruutu M., Syrjanen S., Favalli C., Syrjanen K. Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer. Diagn. Cytopathol. 2006, 34:739-748.
6. Doorbar J., Quint W., Banks L., Bravo I.G., Stoler M., Broker T.R., Stanley M.A. The biology and life-cycle of human papillomaviruses. Vaccine 2012, 30:F55-F70.
7. Gewin L., Myers H., Kiyono T., Galloway D.A. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev. 2004, 18:2269-2282.
8. Henken F.E., De-Castro A.J., Rosl F., Bosch L., Meijer C.J., Snijders P.J., Steenbergen R.D. The functional role of Notch signaling in HPV-mediated transformation is dose-dependent and linked to AP-1 alterations. Cell Oncol. (Dordr.) 2012, 35:77-84.
9. Hoffjan S., Stemmler S. On the role of the epidermal differentiation complex in ichthyosis vulgaris, atopic dermatitis and psoriasis. Br. J. Dermatol. 2007, 157:441-449.
10. Huibregtse J.M., Scheffner M., Howley P.M. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 1991, 10:4129-4135.
11. Katzenellenbogen R.A., Egelkrout E.M., Vliet-Gregg P., Gewin L.C., Gafken P.R., Galloway D.A. NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16E6 expressing cells. J.Virol. 2007, 81:3786-3796.
12. Katzenellenbogen R.A., Vliet-Gregg P., Xu M., Galloway D.A. NFX1-123 increases hTERT expression and telomerase activity posttranscriptionally in human papillomavirus type 16 E6 keratinocytes. J. Virol. 2009, 83:6446-6456.
13. Katzenellenbogen R.A., Vliet-Gregg P., Xu M., Galloway D.A. Cytoplasmic poly(A) binding proteins regulate telomerase activity and cell growth in human papillomavirus type 16 E6-expressing keratinocytes. J. Virol. 2010, 84:12934-12944.
14. Kjaer S.K., van den Brule A.J., Paull G., Svare E.I., Sherman M.E., Thomsen B.L., Suntum M., Bock J.E., Poll P.A., Meijer C.J. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. Br. Med. J. 2002, 325:572.
15. Lathion S., Schaper J., Beard P., Raj K. Notch1 can contribute to viral-induced transformation of primary human keratinocytes. Cancer Res. 2003, 63:8687-8694.
16. Lefort K., Mandinova A., Ostano P., Kolev V., Calpini V., Kolfschoten I., Devgan V., Lieb J., Raffoul W., Hohl D., Neel V., Garlick J., Chiorino G., Dotto G.P. Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases. Genes Dev. 2007, 21:562-577.
17. Maliekal T.T., Bajaj J., Giri V., Subramanyam D., Krishna S. The role of Notch signaling in human cervical cancer: implications for solid tumors. Oncogene 2008, 27:5110-5114.
18. McDade S.S., Patel D., McCance D.J. p63 maintains keratinocyte proliferative capacity through regulation of Skp2-p130 levels. J. Cell Sci. 2011, 124:1635-1643.
19. Moscicki A.B., Schiffman M., Burchell A., Albero G., Giuliano A.R., Goodman M.T., Kjaer S.K., Palefsky J. Updating the natural history of human papillomavirus and anogenital cancers. Vaccine 2012, 30:F24-F33.
20. Muller C., Alunni-Fabbroni M., Kowenz-Leutz E., Mo X., Tommasino M., Leutz A. Separation of C/EBPalpha-mediated proliferation arrest and differentiation pathways. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:7276-7281.
21. Nguyen B.C., Lefort K., Mandinova A., Antonini D., Devgan V., Della G.G., Koster M.I., Zhang Z., Wang J., Tommasi d.V., Kitajewski J., Chiorino G., Roop D.R., Missero C., Dotto G.P. Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev. 2006, 20:1028-1042.
22. Parroche P., Touka M., Mansour M., Bouvard V., Thepot A., Accardi R., Carreira C., Roblot G.G., Sylla B.S., Hasan U., Tommasino M. Human papillomavirus type 16 E6 inhibits p21(WAF1) transcription independently of p53 by inactivating p150(Sal2). Virology 2011, 417:443-448.
23. Pattabiraman C., Hong S., Gunasekharan V.K., Pranatharthi A., Bajaj J., Srivastava S., Krishnamurthy H., Ammothumkandy A., Giri V.G., Laimins L.A., Krishna S. CD66+ cells in cervical pre-cancers are partially differentiated progenitors with neoplastic traits. Cancer Res. 2014.
24. Rangarajan A., Syal R., Selvarajah S., Chakrabarti O., Sarin A., Krishna S. Activated Notch1 signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB/Akt. Virology 2001, 286:23-30.
25. Rangarajan A., Talora C., Okuyama R., Nicolas M., Mammucari C., Oh H., Aster J.C., Krishna S., Metzger D., Chambon P., Miele L., Aguet M., Radtke F., Dotto G.P. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J. 2001, 20:3427-3436.
26. Rodriguez A.C., Schiffman M., Herrero R., Hildesheim A., Bratti C., Sherman M.E., Solomon D., Guillen D., Alfaro M., Morales J., Hutchinson M., Katki H., Cheung L., Wacholder S., Burk R.D. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J. Natl. Cancer Inst. 2010, 102:315-324.
27. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993, 75:495-505.
28. Talora C., Sgroi D.C., Crum C.P., Dotto G.P. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Genes Dev. 2002, 16:2252-2263.
29. Varnum-Finney B., Wu L., Yu M., Brashem-Stein C., Staats S., Flowers D., Griffin J.D., Bernstein I.D. Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling. J. Cell Sci. 2000, 113(Pt 23):4313-4318.
30. Veeraraghavalu K., Pett M., Kumar R.V., Nair P., Rangarajan A., Stanley M.A., Krishna S. Papillomavirus-mediated neoplastic progression is associated with reciprocal changes in JAGGED1 and manic fringe expression linked to notch activation. J. Virol. 2004, 78:8687-8700.
31. Vliet-Gregg P.A., Hamilton J.R., Katzenellenbogen R.A. NFX1-123 and human papillomavirus 16E6 increase Notch expression in keratinocytes. J. Virol. 2013, 87:13741-13750.
32. Warfel N.A., El-Deiry W.S. p21WAF1 and tumourigenesis: 20 years after. Curr. Opin. Oncol. 2013, 25:52-58.
33. Watt F.M., Estrach S., Ambler C.A. Epidermal Notch signalling: differentiation, cancer and adhesion. Curr. Opin. Cell Biol. 2008, 20:171-179.
34. Weijzen S., Zlobin A., Braid M., Miele L., Kast W.M. HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation. J. Cell Physiol. 2003, 194:356-362.
35. Yugawa T., Handa K., Narisawa-Saito M., Ohno S., Fujita M., Kiyono T. Regulation of Notch1 gene expression by p53 in epithelial cells. Mol. Cell Biol. 2007, 27:3732-3742.
36. Yugawa T., Narisawa-Saito M., Yoshimatsu Y., Haga K., Ohno S., Egawa N., Fujita M., Kiyono T. DeltaNp63alpha repression of the Notch1 gene supports the proliferative capacity of normal human keratinocytes and cervical cancer cells. Cancer Res. 2010, 70:4034-4044.
37. Zagouras P., Stifani S., Blaumueller C.M., Carcangiu M.L., Artavanis-Tsakonas S. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:6414-6418.